Alendronate Sodium Tablets SPE2D2-26-D-0009
Summary
AI-generated · Mar 20, 2026Alendronate Sodium Tablets awarded under SPE2D2-25-R-0023 to Exelan Pharmaceuticals Inc. This notice confirms a contract for the supply of Alendronate Sodium Tablets has been awarded to Exelan Pharmaceuticals Inc under the referenced solicitation.
Award for Alendronate Sodium Tablets solicited under SPE2D2-25-R-0023.
From Award Notice posted on Mar 19, 2026Notice history
1-
Award Notice LATEST Posted Mar 19, 2026
Details
Award Information
Award Notices
Posted: Mar 19, 2026
Award for Alendronate Sodium Tablets solicited under SPE2D2-25-R-0023.
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| EXELAN PHARMACEUTICALS INC | FYZXNHSQTMG8 | 6GFC4 | Boca Raton, FL |
Contacts
Phone
Agency
Place of Performance
USA